Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.

We have designed dimeric antibody fragments that assemble in Escherichia coli. They are based on single-chain FV fragments, with a flexible hinge region from mouse IgG3 and an amphiphilic helix fused to the C-terminus of the antibody fragment. The sequence of the helix was taken either from that of a previously reported four-helix bundle design or from a leucine zipper, optionally extended with a short cysteine-containing peptide. The bivalent fragments associate in vivo, either with covalent linkage or with a monomer-dimer equilibrium, and results from ultracentrifugation sedimentation studies and SDS-PAGE are consistent with dimers. All constructs are able to bind to surface-bound antigen under conditions in which only bivalent but not monovalent antibody fragments bind. The covalent bundle helix construct shows binding characteristics nearly identical to those of the much larger whole mouse antibody, resulting in substantially more stable immunoglobulin-antigen complexes than in the case of monovalent fragments. This modular design of natural and engineered protein domains directly leads to a boost of avidity, and it allows the construction of bispecific antibody fragments in functional form in E. coli.

[1]  G. Jung,et al.  An in-vitro model for tumor immunotherapy with antibody heteroconjugates. , 1988, Immunology today.

[2]  P. V. von Hippel,et al.  Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.

[3]  S. Kaufmann,et al.  Progress in Immunology , 1989, Springer Berlin Heidelberg.

[4]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[5]  P. S. Kim,et al.  X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. , 1991, Science.

[6]  A. Plückthun,et al.  The Functional Expression of Antibody Fv Fragments in Ischhuchia coli: Improved Vectors and a Generally Applicable Purification Technique , 1991, Bio/Technology.

[7]  J. Vieira,et al.  Production of single-stranded plasmid DNA. , 1987, Methods in enzymology.

[8]  L. Hood,et al.  The generation of diversity in phosphorylcholine-binding antibodies. , 1984, Advances in immunology.

[9]  M. Potter ANTIGEN‐BINDING MYELOMA PROTEINS IN MICE , 1971, Advances in immunology.

[10]  S. McKnight,et al.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. , 1988, Science.

[11]  A. Plückthun,et al.  Expression of functional antibody Fv and Fab fragments in Escherichia coli. , 1989, Methods in enzymology.

[12]  A. Blondel,et al.  Engineering the quaternary structure of an exported protein with a leucine zipper. , 1991, Protein engineering.

[13]  K. D. Hardman,et al.  In vivo tumor targeting of a recombinant single-chain antigen-binding protein. , 1990, Journal of the National Cancer Institute.

[14]  S. Fling,et al.  Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea. , 1986, Analytical biochemistry.

[15]  D M Crothers,et al.  The influence of polyvalency on the binding properties of antibodies. , 1972, Immunochemistry.

[16]  R. Glockshuber,et al.  Crystallization and preliminary X-ray studies of the VL domain of the antibody McPC603 produced in Escherichia coli. , 1990, Journal of molecular biology.

[17]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[18]  S. Morrison,et al.  Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. , 1988, The EMBO journal.

[19]  R. R. Robinson,et al.  Escherichia coli secretion of an active chimeric antibody fragment. , 1988, Science.

[20]  Y. Satow,et al.  Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. , 1985, Journal of molecular biology.

[21]  P. S. Kim,et al.  Evidence that the leucine zipper is a coiled coil. , 1989, Science.

[22]  A. Plückthun Antibody Engineering: Advances From the Use of Escherichia coli Expression Systems , 1991, Bio/Technology.

[23]  T. N. Bhat,et al.  Small rearrangements in structures of Fv and Fab fragments of antibody D 1.3 on antigen binding , 1990, Nature.

[24]  A. Plückthun Antibodies from Escherichia coli , 1990, Nature.

[25]  S. Challacombe,et al.  ELISA and other solid phase immunoassys : theoretical and practical aspects , 1988 .

[26]  R. Bird,et al.  Single chain antibody variable regions. , 1991, Trends in biotechnology.

[27]  R. Glockshuber,et al.  Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603. , 1991, Biochemistry.

[28]  Thomas A. Kunkel,et al.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J Deisenhofer,et al.  Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. , 1980, Journal of molecular biology.

[30]  D Eisenberg,et al.  The design, synthesis, and crystallization of an alpha‐helical peptide , 1986, Proteins.

[31]  R. Glockshuber,et al.  Structural features of the McPC603 Fab fragment not defined in the X‐ray structure , 1990, FEBS letters.

[32]  L. Regan,et al.  Characterization of a helical protein designed from first principles. , 1988, Science.

[33]  J. Richardson,et al.  The anatomy and taxonomy of protein structure. , 1981, Advances in protein chemistry.

[34]  R. Glockshuber,et al.  A comparison of strategies to stabilize immunoglobulin Fv-fragments. , 1990, Biochemistry.

[35]  B. Chesebro,et al.  Affinity labeling of a phosphorylcholine binding mouse myeloma protein. , 1972, Biochemistry.

[36]  L. Riechmann,et al.  Use of 2D NMR, protein engineering, and molecular modeling to study the hapten-binding site of an antibody Fv fragment against 2-phenyloxazolone. , 1991, Biochemistry.

[37]  A. Plückthun,et al.  Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.

[38]  W. DeGrado,et al.  Design of a 4-helix bundle protein: synthesis of peptides which self-associate into a helical protein , 1987 .

[39]  S. Morrison,et al.  Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  James C. Hu,et al.  Sequence requirements for coiled-coils: analysis with lambda repressor-GCN4 leucine zipper fusions. , 1990, Science.

[41]  D Eisenberg,et al.  Crystal structure of alpha 1: implications for protein design. , 1990, Science.